489 related articles for article (PubMed ID: 22705769)
41. Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.
Carley AN; Taglieri DM; Bi J; Solaro RJ; Lewandowski ED
Circ Heart Fail; 2015 Jan; 8(1):119-27. PubMed ID: 25424393
[TBL] [Abstract][Full Text] [Related]
42. TIGAR Deficiency Blunts Angiotensin-II-Induced Cardiac Hypertrophy in Mice.
He X; Williams QA; Cantrell AC; Besanson J; Zeng H; Chen JX
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397106
[TBL] [Abstract][Full Text] [Related]
43. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
44. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.
Wang L; Zhang YL; Lin QY; Liu Y; Guan XM; Ma XL; Cao HJ; Liu Y; Bai J; Xia YL; Du J; Li HH
Eur Heart J; 2018 May; 39(20):1818-1831. PubMed ID: 29514257
[TBL] [Abstract][Full Text] [Related]
45. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
46. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
[TBL] [Abstract][Full Text] [Related]
47. Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction.
Sun Q; Güven B; Wagg CS; Almeida de Oliveira A; Silver H; Zhang L; Chen B; Wei K; Ketema EB; Karwi QG; Persad KL; Vu J; Wang F; Dyck JRB; Oudit GY; Lopaschuk GD
Cardiovasc Res; 2024 Mar; 120(4):360-371. PubMed ID: 38193548
[TBL] [Abstract][Full Text] [Related]
48. Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice.
Sun Q; Wagg CS; Güven B; Wei K; de Oliveira AA; Silver H; Zhang L; Vergara A; Chen B; Wong N; Wang F; Dyck JRB; Oudit GY; Lopaschuk GD
Basic Res Cardiol; 2024 Feb; 119(1):133-150. PubMed ID: 38148348
[TBL] [Abstract][Full Text] [Related]
49. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
51. p21(CIP1/WAF1)-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling.
Hauck L; Grothe D; Billia F
Peptides; 2016 Sep; 83():38-48. PubMed ID: 27486069
[TBL] [Abstract][Full Text] [Related]
52. Role of Jagged1-Hey1 Signal in Angiotensin II-induced Impairment of Myocardial Angiogenesis.
Guan AL; He T; Shao YB; Chi YF; Dai HY; Wang Y; Xu L; Yang X; Ding HM; Cai SL
Chin Med J (Engl); 2017 Feb; 130(3):328-333. PubMed ID: 28139517
[TBL] [Abstract][Full Text] [Related]
53. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
54. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
[TBL] [Abstract][Full Text] [Related]
55. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
56. Single-Stranded DNA-Binding Protein 1 Abrogates Cardiac Fibroblast Proliferation and Collagen Expression Induced by Angiotensin II.
Tian HP; Sun YH; He L; Yi YF; Gao X; Xu DL
Int Heart J; 2018 Nov; 59(6):1398-1408. PubMed ID: 30369577
[TBL] [Abstract][Full Text] [Related]
57. GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.
Nguyen TD; Shingu Y; Amorim PA; Schenkl C; Schwarzer M; Doenst T
J Cardiovasc Transl Res; 2018 Jun; 11(3):259-267. PubMed ID: 29464655
[TBL] [Abstract][Full Text] [Related]
58. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
59. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
